Sexual dimorphism in predisposition to Alzheimer's disease

Neurobiology of Aging

Volumn 70, Issue , 2018, Pages 308-324

  Fisher, Daniel W ^a   Bennett, David A ^b   Dong, Hongxin ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; APOE; Brain structure; Cognition; Hormones; Sex difference; Stress

Indexed keywords

SEX HORMONE; APOE PROTEIN, HUMAN; APOLIPOPROTEIN E; BDNF PROTEIN, HUMAN; BRAIN DERIVED NEUROTROPHIC FACTOR;

AGED; ALZHEIMER DISEASE; BRAIN DISEASE; DISEASE PREDISPOSITION; FEMALE; HEREDITY; HUMAN; INCIDENCE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SEXUAL CHARACTERISTICS;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; RISK FACTORS; SEX CHARACTERISTICS;

EID: 85046620961     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2018.04.004     Document Type: Review

References (178)

1. Alzheimer Association, Alzheimer's disease facts and figures. Alzheimers Dement 11 (2015), 332–384.
2. Altmann, A., Tian, L., Henderson, V.W., Greicius, M.D., Sex modifies the APOE-related risk of developing Alzheimer disease. Ann. Neurol. 75 (2014), 563–573.
3. Amadori, A., Zamarchi, R., De Silvestro, G., Forza, G., Cavatton, G., Danieli, G.A., Clementi, M., Chieco-Bianchi, L., Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1 (1995), 1279–1283.
4. Ardekani, B.A., Convit, A., Bachman, A.H., Analysis of the MIRIAD data shows sex differences in hippocampal atrophy progression. J. Alzheimers Dis. 50 (2016), 847–857.
5. Asthana, S., Baker, L.D., Craft, S., Stanczyk, F.Z., Veith, R.C., Raskind, M.A., Plymate, S.R., High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 57 (2001), 605–612.
6. Bachman, D.L., Wolf, P.A., Linn, R.T., Knoefel, J.E., Cobb, J.L., Belanger, A.J., White, L.R., D'Agostino, R.B., Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 43:3 Pt 1 (1993), 515–519.
7. Bangasser, D.A., Dong, H., Carroll, J., Plona, Z., Ding, H., Rodriguez, L., McKennan, C., Csernansky, J.G., Seeholzer, S.H., Valentino, R.J., Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer's disease-related signaling. Mol. Psychiatry 22 (2017), 1126–1133.
8. Barnes, L.L., Wilson, R.S., Bienias, J.L., Schneider, J.A., Evans, D.A., Bennett, D.A., Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch. Gen. Psychiatry 62 (2005), 685–691.
9. Behan, D.P., Heinrichs, S.C., Troncoso, J.C., Liu, X.J., Kawas, C.H., Ling, N., De Souza, E.B., Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature 378 (1995), 284–287.
10. Beydoun, M.A., Boueiz, A., Abougergi, M.S., Kitner-Triolo, M.H., Beydoun, H.A., Resnick, S.M., O'Brien, R., Zonderman, A.B., Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment and decline. Neurobiol. Aging, 33, 2012, 720.
11. Blanchard, B.J., Devi Raghunandan, R., Roder, H.M., Ingram, V.M., Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200 (1994), 187–194.
12. Bove, R., Secor, E., Chibnik, L.B., Barnes, L.L., Schneider, J.A., Bennett, D.A., De Jager, P.L., Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology 82 (2014), 222–229.
13. Bradshaw, E.M., Chibnik, L.B., Keenan, B.T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L.L., Imboywa, S., Lee, M., Von Korff, A., Morris, M.C., Evans, D.A., Johnson, K., Sperling, R.A., Schneider, J.A., Bennett, D.A., De Jager, P.L., CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat. Neurosci. 16 (2013), 848–850.
14. Bremner, J.D., Does stress damage the brain?. Biol. Psychiatry 45 (1999), 797–805.
15. Brookmeyer, R., Gray, S., Kawas, C., Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88 (1998), 1337–1342.
16. Bu, G., Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 10 (2009), 333–344.
17. Buchhave, P., Zetterberg, H., Blennow, K., Minthon, L., Janciauskiene, S., Hansson, O., Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol. Aging 31 (2010), 1877–1884.
18. Buttery, A.K., Du, Y., Busch, M.A., Fuchs, J., Gaertner, B., Knopf, H., Scheidt-Nave, C., Changes in physical functioning among men and women aged 50–79 years in Germany: an analysis of National Health Interview and Examination Surveys, 1997–1999 and 2008–2011. BMC Geriatr., 16, 2016, 205.
19. Cagnin, A., Brooks, D.J., Kennedy, A.M., Gunn, R.N., Myers, R., Turkheimer, F.E., Jones, T., Banati, R.B., In-vivo measurement of activated microglia in dementia. Lancet 358 (2001), 461–467.
20. Campbell, S.N., Zhang, C., Monte, L., Roe, A.D., Rice, K.C., Tache, Y., Masliah, E., Rissman, R.A., Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor. J. Alzheimers Dis. 43 (2015), 967–976.
21. Carmelli, D., Swan, G.E., Reed, T., Miller, B., Wolf, P.A., Jarvik, G.P., Schellenberg, G.D., Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 50 (1998), 1580–1585.
22. Carroll, J.C., Iba, M., Bangasser, D.A., Valentino, R.J., James, M.J., Brunden, K.R., Lee, V.M., Trojanowski, J.Q., Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J. Neurosci. 31 (2011), 14436–14449.
23. Chen, J., Liang, X., Li, B., Jiang, X., Xu, Z., Gender-related association of brain-derived neurotrophic factor gene 196A/G polymorphism with Alzheimer's disease—a meta-analysis including 6854 cases and 6868 controls. Int. J. Neurosci. 124 (2014), 724–733.
24. Christensen, A., Pike, C.J., Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice. PLoS One, 12, 2017, e0178490.
25. Cooper, G.S., Stroehla, B.C., The epidemiology of autoimmune diseases. Autoimmun. Rev. 2 (2003), 119–125.
26. Cordey, M., Gundimeda, U., Gopalakrishna, R., Pike, C.J., Estrogen activates protein kinase C in neurons: role in neuroprotection. J. Neurochem. 84 (2003), 1340–1348.
27. Crimmins, E.M., Kim, J.K., Solé-Auró A., Gender differences in health: results from SHARE, ELSA and HRS. Eur. J. Public Health, 21, 2011, 81.
28. Csernansky, J.G., Dong, H., Fagan, A.M., Wang, L., Xiong, C., Holtzman, D.M., Morris, J.C., Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am. J. Psychiatry 163 (2006), 2164–2169.
29. Cuadrado-Tejedor, M., Ricobaraza, A., Frechilla, D., Franco, R., Perez-Mediavilla, A., Garcia-Osta, A., Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice. J. Alzheimers Dis. 28 (2012), 567–578.
30. Cui, J., Shen, Y., Li, R., Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol. Med. 19 (2013), 197–209.
31. da Cruz e Silva, O.A., Rebelo, S., Vieira, S.I., Gandy, S., da Cruz e Silva, E.F., Greengard, P., Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C. J. Neurochem. 108 (2009), 319–330.
32. Damoiseaux, J.S., Seeley, W.W., Zhou, J., Shirer, W.R., Coppola, G., Karydas, A., Rosen, H.J., Miller, B.L., Kramer, J.H., Greicius, M.D., Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J. Neurosci. 32 (2012), 8254–8262.
33. De Souza, E.B., Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20 (1995), 789–819.
34. Deak, T., Quinn, M., Cidlowski, J.A., Victoria, N.C., Murphy, A.Z., Sheridan, J.F., Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for pharmacotherapy of stress-related disease. Stress, 18, 2015, 367.
35. DeKosky, S.T., Scheff, S.W., Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27 (1990), 457–464.
36. Devi, L., Alldred, M.J., Ginsberg, S.D., Ohno, M., Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Mol. Brain, 3, 2010, 34.
37. Dong, H., Goico, B., Martin, M., Csernansky, C.A., Bertchume, A., Csernansky, J.G., Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 127 (2004), 601–609.
38. Dong, H., Yuede, C.M., Coughlan, C., Lewis, B., Csernansky, J.G., Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease. Neuropsychopharmacology 33 (2008), 3226–3236.
39. Edison, P., Archer, H.A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F.E., Hammers, A., Tai, Y.F., Fox, N., Kennedy, A., Rossor, M., Brooks, D.J., Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol. Dis. 32 (2008), 412–419.
40. Edland, S.D., Rocca, W.A., Petersen, R.C., Cha, R.H., Kokmen, E., Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch. Neurol. 59 (2002), 1589–1593.
41. Elbejjani, M., Fuhrer, R., Abrahamowicz, M., Mazoyer, B., Crivello, F., Tzourio, C., Dufouil, C., Depression, depressive symptoms, and rate of hippocampal atrophy in a longitudinal cohort of older men and women. Psychol. Med. 45 (2015), 1931–1944.
42. Engelhart, M.J., Geerlings, M.I., Meijer, J., Kiliaan, A., Ruitenberg, A., Swieten, J.C., Stijnen, T., Hofman, A., Witteman, J.C., Breteler, M.M., Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study. Arch. Neurol. 61 (2004), 668–672.
43. Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N., van Duijn, C.M., Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (1997), 1349–1356.
44. Femminella, G.D., Rengo, G., Pagano, G., de Lucia, C., Komici, K., Parisi, V., Cannavo, A., Liccardo, D., Vigorito, C., Filardi, P.P., Ferrara, N., Leosco, D., beta-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?. J. Alzheimers Dis. 34 (2013), 341–347.
45. Ferencz, B., Gerritsen, L., Genetics and underlying pathology of dementia. Neuropsychol. Rev. 25 (2015), 113–124.
46. Fiest, K.M., Roberts, J.I., Maxwell, C.J., Hogan, D.B., Smith, E.E., Frolkis, A., Cohen, A., Kirk, A., Pearson, D., Pringsheim, T., Venegas-Torres, A., Jetté N., The prevalence and incidence of dementia due to Alzheimer's disease: a systematic review and meta-analysis. Can. J. Neurol. Sci. 43 (2016), S51–S82.
47. Fleisher, A., Grundman, M., Jack, C.R. Jr., Petersen, R.C., Taylor, C., Kim, H.T., Schiller, D.H., Bagwell, V., Sencakova, D., Weiner, M.F., DeCarli, C., DeKosky, S.T., van Dyck, C.H., Thal, L.J., Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch. Neurol. 62 (2005), 953–957.
48. Fratiglioni, L., Launer, L.J., Andersen, K., Breteler, M.M., Copeland, J.R., Dartigues, J.F., Lobo, A., Martinez-Lage, J., Soininen, H., Hofman, A., Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54:11 Suppl 5 (2000), S10–S15.
49. Freedman, V.A., Wolf, D.A., Spillman, B.C., Disability-Free life expectancy over 30 Years: a growing female disadvantage in the US population. Am. J. Public Health 106 (2016), 1079–1085.
50. Fukumoto, N., Fujii, T., Combarros, O., Kamboh, M.I., Tsai, S.-J., Matsushita, S., Nacmias, B., Comings, D.E., Arboleda, H., Ingelsson, M., Hyman, B.T., Akatsu, H., Grupe, A., Nishimura, A.L., Zatz, M., Mattila, K.M., Rinne, J., Goto, Y.-i., Asada, T., Nakamura, S., Kunugi, H., Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: new data and meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (2010), 235–242.
51. Gaillard, R.C., Spinedi, E., Sex- and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphism. Domest. Anim. Endocrinol. 15 (1998), 345–352.
52. Galasko, D., Chang, L., Motter, R., Clark, C.M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I., Miller, B., Green, R., Basherad, R., Kertiles, L., Boss, M.A., Seubert, P., High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch. Neurol. 55 (1998), 937–945.
53. Gale, S.D., Baxter, L., Thompson, J., Greater memory impairment in dementing females than males relative to sex-matched healthy controls. J. Clin. Exp. Neuropsychol. 6 (2016), 1–7.
54. Gallart-Palau, X., Lee, B.S., Adav, S.S., Qian, J., Serra, A., Park, J.E., Lai, M.K., Chen, C.P., Kalaria, R.N., Sze, S.K., Gender differences in white matter pathology and mitochondrial dysfunction in Alzheimer's disease with cerebrovascular disease. Mol. Brain, 9, 2016, 27.
55. Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Fiske, A., Pedersen, N.L., Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63 (2006), 168–174.
56. Gleicher, N., Barad, D.H., Gender as risk factor for autoimmune diseases. J. Autoimmun. 28 (2007), 1–6.
57. Goodenough, S., Engert, S., Behl, C., Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci. Lett. 296 (2000), 49–52.
58. Graves, B.M., Strand, M., Lindsay, A.R., A reassessment of sexual dimorphism in human senescence: theory, evidence, and causation. Am. J. Hum. Biol. 18 (2006), 161–168.
59. Green, K.N., Billings, L.M., Roozendaal, B., McGaugh, J.L., LaFerla, F.M., Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26 (2006), 9047–9056.
60. Green, P.S., Simpkins, J.W., Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18 (2000), 347–358.
61. Griciuc, A., Serrano-Pozo, A., Parrado, A.R., Lesinski, A.N., Asselin, C.N., Mullin, K., Hooli, B., Choi, S.H., Hyman, B.T., Tanzi, R.E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78 (2013), 631–643.
62. Grimm, A., Biliouris, E.E., Lang, U.E., Gotz, J., Mensah-Nyagan, A.G., Eckert, A., Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-beta or hyperphosphorylated tau protein. Cell Mol. Life Sci. 73 (2016), 201–215.
63. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J.S., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J.C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., Hardy, J., TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368 (2013), 117–127.
64. Gustafson, L., Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch. Gerontol. Geriatr. 6 (1987), 209–223.
65. Hanamsagar, R., Bilbo, S.D., Sex differences in neurodevelopmental and neurodegenerative disorders: focus on microglial function and neuroinflammation during development. J. Steroid Biochem. Mol. Biol., 160, 2016, 127.
66. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A., Morgan, A.R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M.K., Brayne, C., Rubinsztein, D.C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K.S., Passmore, P.A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A.D., Love, S., Kehoe, P.G., Hardy, J., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., Heun, R., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A.M., Kauwe, J.S., Cruchaga, C., Nowotny, P., Morris, J.C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Livingston, G., Bass, N.J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C.E., Tsolaki, M., Singleton, A.B., Guerreiro, R., Muhleisen, T.W., Nothen, M.M., Moebus, S., Jockel, K.H., Klopp, N., Wichmann, H.E., Carrasquillo, M.M., Pankratz, V.S., Younkin, S.G., Holmans, P.A., O'Donovan, M., Owen, M.J., Williams, J., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41 (2009), 1088–1093.
67. Hebert, L.E., Scherr, P.A., McCann, J.J., Beckett, L.A., Evans, D.A., Is the risk of developing Alzheimer's disease greater for women than for men?. Am. J. Epidemiol. 153 (2001), 132–136.
68. Hebert, L.E., Weuve, J., Scherr, P.A., Evans, D.A., Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80 (2013), 1778–1783.
69. Henderson, V.W., Paganini-Hill, A., Miller, B.L., Elble, R.J., Reyes, P.F., Shoupe, D., McCleary, C.A., Klein, R.A., Hake, A.M., Farlow, M.R., Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54 (2000), 295–301.
70. Heneka, M.T., Carson, M.J., Khoury, J.E., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M., Herrup, K., Frautschy, S.A., Finsen, B., Brown, G.C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G.C., Town, T., Morgan, D., Shinohara, M.L., Perry, V.H., Holmes, C., Bazan, N.G., Brooks, D.J., Hunot, S., Joseph, B., Deigendesch, N., Garaschuk, O., Boddeke, E., Dinarello, C.A., Breitner, J.C., Cole, G.M., Golenbock, D.T., Kummer, M.P., Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14 (2015), 388–405.
71. Holland, D., Desikan, R.S., Dale, A.M., McEvoy, L.K., Higher rates of decline for women and APOE ε4 carriers. AJNR Am. J. Neuroradiol., 34, 2013, 2287.
72. Holmes, C., Review: systemic inflammation and Alzheimer's disease. Neuropathol. Appl. Neurobiol. 39 (2013), 51–68.
73. Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., Perry, V.H., Systemic inflammation and disease progression in Alzheimer disease. Neurology 73 (2009), 768–774.
74. Hong, S., Beja-Glasser, V.F., Nfonoyim, B.M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K.M., Shi, Q., Rosenthal, A., Barres, B.A., Lemere, C.A., Selkoe, D.J., Stevens, B., Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science, 352, 2016, 712.
75. Hoogendijk, W.J., Meynen, G., Endert, E., Hofman, M.A., Swaab, D.F., Increased cerebrospinal fluid cortisol level in Alzheimer's disease is not related to depression. Neurobiol. Aging 27 (2006), 780.e1–780.e2.
76. Hua, X., Hibar, D.P., Lee, S., Toga, A.W., Jack, C.R. Jr., Weiner, M.W., Thompson, P.M., Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans. Neurobiol. Aging 31 (2010), 1463–1480.
77. Hwang, C.J., Park, M.H., Choi, M.K., Choi, J.S., Oh, K.W., Hwang, D.Y., Han, S.B., Hong, J.T., Acceleration of amyloidogenesis and memory impairment by estrogen deficiency through NF-kappaB dependent beta-secretase activation in presenilin 2 mutant mice. Brain Behav. Immun. 53 (2016), 113–122.
78. Irvine, K., Laws, K.R., Gale, T.M., Kondel, T.K., Greater cognitive deterioration in women than men with Alzheimer's disease: a meta analysis. J. Clin. Exp. Neuropsychol. 34 (2012), 989–998.
79. Jagger, C., Matthews, F.E., Wohland, P., Fouweather, T., Stephan, B.C.M., Robinson, L., Arthur, A., Brayne, C., Medical Research Council Cognitive Function and Ageing Collaboration. A comparison of health expectancies over two decades in England: results of the Cognitive Function and Ageing Study I and II. Lancet 387 (2016), 779–786.
80. Janicki, S.C., Park, N., Cheng, R., Clark, L.N., Lee, J.H., Schupf, N., Estrogen receptor alpha variants affect age at onset of Alzheimer's disease in a multiethnic female cohort. Dement. Geriatr. Cogn. Disord. 38 (2014), 200–213.
81. Jeong, Y.H., Park, C.H., Yoo, J., Shin, K.Y., Ahn, S.M., Kim, H.S., Lee, S.H., Emson, P.C., Suh, Y.H., Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. FASEB J. 20 (2006), 729–731.
82. Ji, K., Akgul, G., Wollmuth, L.P., Tsirka, S.E., Microglia actively regulate the number of functional synapses. PLoS One, 8, 2013, e56293.
83. Jin, J.-J., Kim, H.-D., Maxwell, J.A., Li, L., Fukuchi, K.-i., Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J. Neuroinflammation, 5, 2008, 23.
84. Kang, J.E., Cirrito, J.R., Dong, H., Csernansky, J.G., Holtzman, D.M., Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 10673–10678.
85. Kivity, S., Ehrenfeld, M., Can we explain the higher prevalence of autoimmune disease in women?. Expert Rev. Clin. Immunol. 6 (2010), 691–694.
86. Klein, S.L., The effects of hormones on sex differences in infection: from genes to behavior. Neurosci. Biobehav. Rev. 24 (2000), 627–638.
87. Koran, M.E., Wagener, M., Hohman, T.J., Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behav. 11 (2017), 205–213.
88. Kovacs, E.J., Messingham, K.A.N., Gregory, M.S., Estrogen regulation of immune responses after injury. Mol. Cell Endocrinol. 193 (2002), 129–135.
89. Kowiański, P., Lietzau, G., Czuba, E., Waśkow, M., Steliga, A., Moryś J., BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol. Neurobiol. 38:3 (2017), 579–593.
90. Kukull, W.A., Higdon, R., Bowen, J.D., McCormick, W.C., Teri, L., Schellenberg, G.D., Belle, G.V., Jolley, L., Larson, E.B., Dementia and Alzheimer disease incidence: a prospective cohort study. Arch. Neurol. 59 (2002), 1737–1746.
91. Lambert, J.C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M.J., Tavernier, B., Letenneur, L., Bettens, K., Berr, C., Pasquier, F., Fievet, N., Barberger-Gateau, P., Engelborghs, S., De Deyn, P., Mateo, I., Franck, A., Helisalmi, S., Porcellini, E., Hanon, O., de Pancorbo, M.M., Lendon, C., Dufouil, C., Jaillard, C., Leveillard, T., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossu, P., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Hannequin, D., Licastro, F., Soininen, H., Ritchie, K., Blanche, H., Dartigues, J.F., Tzourio, C., Gut, I., Van Broeckhoven, C., Alperovitch, A., Lathrop, M., Amouyel, P., Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41 (2009), 1094–1099.
92. Laurin, D., David Curb, J., Masaki, K.H., White, L.R., Launer, L.J., Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiol. Aging 30 (2009), 1724–1727.
93. Lehmann, D.J., Refsum, H., Nurk, E., Warden, D.R., Tell, G.S., Vollset, S.E., Engedal, K., Nygaard, H.A., Smith, A.D., Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study. J. Neurol. Neurosurg. Psychiatry 77 (2006), 902–908.
94. Lenz, K.M., McCarthy, M.M., A starring role for microglia in brain sex differences. Neuroscientist 21 (2015), 306–321.
95. Levin-Allerhand, J.A., Smith, J.D., Ovariectomy of young mutant amyloid precursor protein transgenic mice leads to increased mortality. J. Mol. Neurosci. 19 (2002), 163–166.
96. Li, G., Shofer, J.B., Petrie, E.C., Yu, C.-E., Wilkinson, C.W., Figlewicz, D.P., Shutes-David, A., Zhang, J., Montine, T.J., Raskind, M.A., Quinn, J.F., Galasko, D.R., Peskind, E.R., Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimers Res. Ther., 9, 2017, 48.
97. Li, G.-D., Bi, R., Zhang, D.-F., Xu, M., Luo, R., Wang, D., Fang, Y., Li, T., Zhang, C., Yao, Y.-G., Female-specific effect of the BDNF gene on Alzheimer's disease. Neurobiol. Aging 53 (2017), 192.e11–192.e19.
98. Lim, Y.Y., Villemagne, V.L., Laws, S.M., Pietrzak, R.H., Snyder, P.J., Ames, D., Ellis, K.A., Harrington, K., Rembach, A., Martins, R.N., Rowe, C.C., Masters, C.L., Maruff, P., APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease. Mol. Psychiatry 20 (2015), 1322–1328.
99. Lin, K.A., Choudhury, K.R., Rathakrishnan, B.G., Marks, D.M., Petrella, J.R., Doraiswamy, P.M., Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement (N Y) 1 (2015), 103–110.
100. Lin, K.A., Doraiswamy, P.M., When mars versus venus is not a cliche: gender differences in the neurobiology of Alzheimer's disease. Front. Neurol., 5, 2014, 288.
101. Liu, C.C., Kanekiyo, T., Xu, H., Bu, G., Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9 (2013), 106–118.
102. Lue, L.F., Brachova, L., Civin, W.H., Rogers, J., Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J. Neuropathol. Exp. Neurol. 55 (1996), 1083–1088.
103. Masters, C.L., Bateman, R., Blennow, K., Rowe, C.C., Sperling, R.A., Cummings, J.L., Alzheimer's disease. Nat. Rev. Dis. Primers, 1, 2015, 15056.
104. Matyi, J., Tschanz, J.T., Rattinger, G.B., Sanders, C., Vernon, E.K., Corcoran, C., Kauwe, J.S.K., Buhusi, M., Sex differences in risk for Alzheimer's disease related to neurotrophin gene polymorphisms: the Cache county memory study. J. Gerontol. A. Biol. Sci. Med. Sci. 72 (2017), 1607–1613.
105. McClelland, E.E., Smith, J.M., Gender specific differences in the immune response to infection. Arch. Immunol. Ther. Exp. 59 (2011), 203–213.
106. Miech, R.A., Breitner, J.C., Zandi, P.P., Khachaturian, A.S., Anthony, J.C., Mayer, L., Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology 58:2 (2002), 209–218.
107. Mielke, M.M., Vemuri, P., Rocca, W.A., Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin. Epidemiol. 6 (2014), 37–48.
108. Morrison, J.H., Brinton, R.D., Schmidt, P.J., Gore, A.C., Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J. Neurosci. 26 (2006), 10332–10348.
109. Mortensen, E.L., Hogh, P., A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 57 (2001), 89–95.
110. Mucke, L., Selkoe, D.J., Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harbor Perspect. Med., 2, 2012, a006338.
111. Mulnard, R.A., Cotman, C.W., Kawas, C., van Dyck, C.H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., Grundman, M., Thomas, R., Thal, L.J., Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283 (2000), 1007–1015.
112. Neu, S.C., Pa, J., Kukull, W., Beekly, D., Kuzma, A., Gangadharan, P., Wang, L.-S., Romero, K., Arneric, S.P., Redolfi, A., Orlandi, D., Frisoni, G.B., Au, R., Devine, S., Auerbach, S., Espinosa, A., Boada, M., Ruiz, A., Johnson, S.C., Koscik, R., Wang, J.-J., Hsu, W.-C., Chen, Y.-L., Toga, A.W., Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA Neurol. 74 (2017), 1178–1189.
113. O'Brien, J.T., Ames, D., Schweitzer, I., Colman, P., Desmond, P., Tress, B., Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. Br. J. Psychiatry 168 (1996), 679–687.
114. Overk, C.R., Perez, S.E., Ma, C., Taves, M.D., Soma, K.K., Mufson, E.J., Sex steroid levels and AD-like pathology in 3xTgAD mice. J. Neuroendocrinol. 25 (2013), 131–144.
115. Paganini-Hill, A., Henderson, V.W., Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140 (1994), 256–261.
116. Park, H.J., Ran, Y., Jung, J.I., Holmes, O., Price, A.R., Smithson, L., Ceballos-Diaz, C., Han, C., Wolfe, M.S., Daaka, Y., Ryabinin, A.E., Kim, S.H., Hauger, R.L., Golde, T.E., Felsenstein, K.M., The stress response neuropeptide CRF increases amyloid-beta production by regulating gamma-secretase activity. EMBO J. 34 (2015), 1674–1686.
117. Patel, N.S., Paris, D., Mathura, V., Quadros, A.N., Crawford, F.C., Mullan, M.J., Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J. Neuroinflammation, 2, 2005, 9.
118. Payami, H., Montee, K.R., Kaye, J.A., Bird, T.D., Yu, C.E., Wijsman, E.M., Schellenberg, G.D., Alzheimer's disease, apolipoprotein E4, and gender. JAMA 271 (1994), 1316–1317.
119. Pedersen, W.A., Wan, R., Mattson, M.P., Impact of aging on stress-responsive neuroendocrine systems. Mech. Ageing Dev. 122 (2001), 963–983.
120. Perry, V.H., Holmes, C., Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 10 (2014), 217–224.
121. Pike, C.J., Carroll, J.C., Rosario, E.R., Barron, A.M., Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 30 (2009), 239–258.
122. Plassman, B.L., Langa, K.M., Fisher, G.G., Heeringa, S.G., Weir, D.R., Ofstedal, M.B., Burke, J.R., Hurd, M.D., Potter, G.G., Rodgers, W.L., Steffens, D.C., Willis, R.J., Wallace, R.B., Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29 (2007), 125–132.
123. Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P., Gauthier, S., Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342 (1993), 697–699.
124. Qin, X.Y., Cao, C., Cawley, N.X., Liu, T.T., Yuan, J., Loh, Y.P., Cheng, Y., Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277). Mol. Psychiatry 22 (2017), 312–320.
125. Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R.E., Mahley, R.W., Mucke, L., Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 10914–10919.
126. Rasmuson, S., Nasman, B., Olsson, T., Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease. Int. Psychogeriatr. 23 (2011), 1386–1392.
127. Rehman, H.U., Role of CRH in the pathogenesis of dementia of Alzheimer's type and other dementias. Curr. Opin. Investig. Drugs 3 (2002), 1637–1642.
128. Reisberg, B., Borenstein, J., Salob, S.P., Ferris, S.H., Franssen, E., Georgotas, A., Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J. Clin. Psychiatry 48:Suppl (1987), 9–15.
129. Riedel, B.C., Thompson, P.M., Brinton, R.D., Age, APOE and sex: triad of risk of Alzheimer's disease. J. Steroid Biochem. Mol. Biol. 160 (2016), 134–147.
130. Rissman, R.A., Staup, M.A., Lee, A.R., Justice, N.J., Rice, K.C., Vale, W., Sawchenko, P.E., Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 6277–6282.
131. Robert, S.J., Zugaza, J.L., Fischmeister, R., Gardier, A.M., Lezoualc'h, F., The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 276 (2001), 44881–44888.
132. Roberts, R.O., Geda, Y.E., Knopman, D.S., Cha, R.H., Pankratz, V.S., Boeve, B.F., Tangalos, E.G., Ivnik, R.J., Rocca, W.A., Petersen, R.C., The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 78 (2012), 342–351.
133. Rocca, W.A., Cha, R.H., Waring, S.C., Kokmen, E., Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am. J. Epidemiol. 148 (1998), 51–62.
134. Rocca, W.A., Grossardt, B.R., Shuster, L.T., Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res. 1379 (2011), 188–198.
135. Rohe, M., Synowitz, M., Glass, R., Paul, S.M., Nykjaer, A., Willnow, T.E., Brain-Derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression. J. Neurosci. 29 (2009), 15472–15478.
136. Rosario, E.R., Carroll, J., Pike, C.J., Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res. 1359 (2010), 281–290.
137. Rosario, E.R., Chang, L., Head, E.H., Stanczyk, F.Z., Pike, C.J., Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol. Aging 32 (2011), 604–613.
138. Sampedro, F., Vilaplana, E., de Leon, M.J., Alcolea, D., Pegueroles, J., Montal, V., Carmona-Iragui, M., Sala, I., Sanchez-Saudinos, M.B., Anton-Aguirre, S., Morenas-Rodriguez, E., Camacho, V., Falcon, C., Pavia, J., Ros, D., Clarimon, J., Blesa, R., Lleo, A., Fortea, J., APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls. Oncotarget 6 (2015), 26663–26674.
139. Sanchez-Mut, J.V., Aso, E., Heyn, H., Matsuda, T., Bock, C., Ferrer, I., Esteller, M., Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease. Hippocampus 24 (2014), 363–368.
140. Sarkar, S., Jun, S., Simpkins, J.W., Estrogen amelioration of Abeta-induced defects in mitochondria is mediated by mitochondrial signaling pathway involving ERbeta, AKAP and Drp1. Brain Res. 1616 (2015), 101–111.
141. Scharfman, H.E., MacLusky, N.J., Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS. Front. Neuroendocrinol. 27 (2006), 415–435.
142. Schneider, J.A., Arvanitakis, Z., Leurgans, S.E., Bennett, D.A., The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol. 66 (2009), 200–208.
143. Schwarz, J.M., Sholar, P.W., Bilbo, S.D., Sex differences in microglial colonization of the developing rat brain. J. Neurochem., 120, 2012, 948.
144. Selmi, C., The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract. Res. Clin. Rheumatol. 22 (2008), 913–922.
145. Sen, A., Nelson, T.J., Alkon, D.L., ApoE4 and Aβ oligomers reduce BDNF expression via HDAC nuclear translocation. J. Neurosci. 35 (2015), 7538–7551.
146. Sen, A., Nelson, T.J., Alkon, D.L., ApoE isoforms differentially regulates cleavage and secretion of BDNF. Mol. Brain, 10, 2017, 19.
147. Seshadri, S., Wolf, P.A., Beiser, A., Au, R., McNulty, K., White, R., D'Agostino, R.B., Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology 49 (1997), 1498–1504.
148. Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K., Hendrix, S.L., Jones, B.N. 3rd, Assaf, A.R., Jackson, R.D., Kotchen, J.M., Wassertheil-Smoller, S., Wactawski-Wende, J., Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003), 2651–2662.
149. Sierksma, A.S., Vanmierlo, T., De Vry, J., Raijmakers, M.E., Steinbusch, H.W., van den Hove, D.L., Prickaerts, J., Effects of prenatal stress exposure on soluble Abeta and brain-derived neurotrophic factor signaling in male and female APPswe/PS1dE9 mice. Neurochem. Int. 61 (2012), 697–701.
150. Sotiropoulos, I., Silva, J., Kimura, T., Rodrigues, A.J., Costa, P., Almeida, O.F., Sousa, N., Takashima, A., Female hippocampus vulnerability to environmental stress, a precipitating factor in Tau aggregation pathology. J. Alzheimers Dis. 43 (2015), 763–774.
151. Sundermann, E.E., Biegon, A., Rubin, L.H., Lipton, R.B., Landau, S., Maki, P.M., Does the female advantage in verbal memory contribute to underestimating Alzheimer's disease pathology in women versus men?. J. Alzheimers Dis. 56 (2017), 947–957.
152. Sundermann, E.E., Biegon, A., Rubin, L.H., Lipton, R.B., Mowrey, W., Landau, S., Maki, P.M., Alzheimer's Disease Neuroimaging Initiative. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy. Neurology 86 (2016), 1368–1376.
153. Swanwick, G.R., Kirby, M., Bruce, I., Buggy, F., Coen, R.F., Coakley, D., Lawlor, B.A., Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings. Am. J. Psychiatry 155 (1998), 286–289.
154. Tai, L.M., Thomas, R., Marottoli, F.M., Koster, K.P., Kanekiyo, T., Morris, A.W.J., Bu, G., The role of APOE in cerebrovascular dysfunction. Acta. Neuropathol. 131 (2016), 709–723.
155. Tamagno, E., Guglielmotto, M., Giliberto, L., Vitali, A., Borghi, R., Autelli, R., Danni, O., Tabaton, M., JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. Neurobiol. Aging 30 (2009), 1563–1573.
156. Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., Mayeux, R., Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996), 429–432.
157. Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., Katzman, R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991), 572–580.
158. Thathiah, A., De Strooper, B., The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nat. Rev. Neurosci. 12 (2011), 73–87.
159. Thathiah, A., Horre, K., Snellinx, A., Vandewyer, E., Huang, Y., Ciesielska, M., De Kloe, G., Munck, S., De Strooper, B., Beta-arrestin 2 regulates Abeta generation and gamma-secretase activity in Alzheimer's disease. Nat. Med. 19 (2013), 43–49.
160. Trojanowski, J.Q., Revesz, T., Neuropathology Working Group on, M.S.A. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol. Appl. Neurobiol. 33 (2007), 615–620.
161. Umegaki, H., Ikari, H., Nakahata, H., Endo, H., Suzuki, Y., Ogawa, O., Nakamura, A., Yamamoto, T., Iguchi, A., Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study. Brain Res. 881 (2000), 241–243.
162. Ungar, L., Altmann, A., Greicius, M.D., Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. Brain Imaging Behav. 8 (2014), 262–273.
163. Verdile, G., Laws, S.M., Henley, D., Ames, D., Bush, A.I., Ellis, K.A., Faux, N.G., Gupta, V.B., Li, Q.X., Masters, C.L., Pike, K.E., Rowe, C.C., Szoeke, C., Taddei, K., Villemagne, V.L., Martins, R.N., Associations between gonadotropins, testosterone and beta amyloid in men at risk of Alzheimer's disease. Mol. Psychiatry 19 (2014), 69–75.
164. Wahrendorf, M., Reinhardt, J.D., Siegrist, J., Relationships of disability with age among adults aged 50 to 85: evidence from the United States, England and Continental Europe. PLoS One, 8, 2013, e71893.
165. Wang, J., Tanila, H., Puolivali, J., Kadish, I., van Groen, T., Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol. Dis. 14 (2003), 318–327.
166. Wang, P.N., Liao, S.Q., Liu, R.S., Liu, C.Y., Chao, H.T., Lu, S.R., Yu, H.Y., Wang, S.J., Liu, H.C., Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54 (2000), 2061–2066.
167. Wang, Y., Cella, M., Mallinson, K., Ulrich, J.D., Young, K.L., Robinette, M.L., Gifillian, S., Krishnan, G.M., Sudhakar, S., Zinselmeyer, B.H., Holtzman, D.M., Cirrito, J.R., Colonna, M., TREM2 lipid sensing sustains microglia response in an Alzheimer's disease model. Cell, 160, 2015, 1061.
168. Wang, Y.Q., Qu, D.H., Wang, K., Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein. Eur. Rev. Med. Pharmacol. Sci. 20 (2016), 2389–2403.
169. Ward, D.D., Summers, M.J., Saunders, N.L., Janssen, P., Stuart, K.E., Vickers, J.C., APOE and BDNF Val66Met polymorphisms combine to influence episodic memory function in older adults. Behav. Brain Res. 271 (2014), 309–315.
170. Whiteford, H.A., Ferrari, A.J., Degenhardt, L., Feigin, V., Vos, T., The global burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010. PLoS One, 10, 2015, e0116820.
171. Whitmer, R.A., Sidney, S., Selby, J., Johnston, S.C., Yaffe, K., Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64 (2005), 277–281.
172. Willem, M., Tahirovic, S., Busche, M.A., Ovsepian, S.V., Chafai, M., Kootar, S., Hornburg, D., Evans, L.D., Moore, S., Daria, A., Hampel, H., Muller, V., Giudici, C., Nuscher, B., Wenninger-Weinzierl, A., Kremmer, E., Heneka, M.T., Thal, D.R., Giedraitis, V., Lannfelt, L., Muller, U., Livesey, F.J., Meissner, F., Herms, J., Konnerth, A., Marie, H., Haass, C., Eta-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature 526 (2015), 443–447.
173. Wolfe, M.S., Alzheimer's gamma-secretase under arrestin. Nat. Med. 19 (2013), 22–24.
174. Xu, H., Sweeney, D., Greengard, P., Gandy, S., Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 4081–4084.
175. Yeh, F.-C., Kao, C.-F., Kuo, P.-H., Explore the features of brain-derived neurotrophic factor in mood disorders. PLoS One, 10, 2015, e0128605.
176. Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C., Breitner, J.C.S., Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache county study. JAMA 288 (2002), 2123–2129.
177. Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A.A., Zhang, C., Xie, T., Tran, L., Dobrin, R., Fluder, E., Clurman, B., Melquist, S., Narayanan, M., Suver, C., Shah, H., Mahajan, M., Gillis, T., Mysore, J., MacDonald, M.E., Lamb, J.R., Bennett, D.A., Molony, C., Stone, D.J., Gudnason, V., Myers, A.J., Schadt, E.E., Neumann, H., Zhu, J., Emilsson, V., Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153 (2013), 707–720.
178. Zheng, H., Xu, H., Uljon, S.N., Gross, R., Hardy, K., Gaynor, J., Lafrancois, J., Simpkins, J., Refolo, L.M., Petanceska, S., Wang, R., Duff, K., Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem. 80 (2002), 191–196.